Literature DB >> 13354039

The effects of reserpine on schizophrenic patients.

S G ARMITAGE, P D GREENBERG, A L OLSEN, D PEARL, H VANDER KAMP.   

Abstract

Entities:  

Keywords:  RESERPINE/therapeutic use; SCHIZOPHRENIA/therapy

Mesh：

Substances：

Year:  1956        PMID： 13354039     DOI： 10.1001/archneurpsyc.1956.02330260084008

Source DB:  PubMed          Journal:  AMA Arch Neurol Psychiatry        ISSN： 0096-6886


× No keyword cloud information.
  5 in total

Review 1.  Past and present progress in the pharmacologic treatment of schizophrenia.

Authors:  John M Kane; Christoph U Correll
Journal:  J Clin Psychiatry       Date:  2010-09       Impact factor: 4.384

2.  Differential effects of chlorpromazine and reserpine.

Authors:  D PEARL; L HERMAN; H VANDER KAMP; A OLSEN; S G ARMITAGE
Journal:  Psychiatr Q       Date:  1958-07

3.  [Clinical experiences in reserpine therapy of schizophrenic psychoses with special reference to the relationship somatic findings & EEG].

Authors:  H BAYREUTHER; H RADTKE
Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr       Date:  1958

Review 4.  Control interventions in randomised trials among people with mental health disorders.

Authors:  Erlend Faltinsen; Adnan Todorovac; Laura Staxen Bruun; Asbjørn Hróbjartsson; Christian Gluud; Mickey T Kongerslev; Erik Simonsen; Ole Jakob Storebø
Journal:  Cochrane Database Syst Rev       Date:  2022-04-04

5.  RMI-81,582, a novel antipsychotic drug.

Authors:  M A Young; H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  1980-01       Impact factor: 4.530
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.